Giuseppe
Emeritus
[Source: European Centre for Disease Prevention and Control (ECDC), full PDF document: (LINK). Abstract, edited.]
Joint European Centre for Disease Prevention and Control and WHO Regional Office for Europe Consultation on pandemic and all hazard preparedness, 20?21 November 2013 - Bratislava, Slovakia
ABSTRACT
The joint European Centre for Disease Prevention and Control and WHO Regional Office for Europe consultation on pandemic and all-hazard preparedness was held on 20?21 November 2013 in Bratislava, Slovakia. Participants included 80 national focal points for pandemic influenza planning, preparedness and response, and International Health Regulations from the European Union (EU), the European Economic Area, south-eastern Europe, Israel, Switzerland and Turkey. The meeting focussed on cross-cutting issues related to pandemic and all-hazards preparedness in light of the implementation of the IHR and the recently adopted EU Decision 1082/2013/EU on serious cross-border threats to health. Topics including risk mapping, risk assessment and multisectoral coordination were addressed, as was the importance of having compatible preparedness plans both within and between countries. Continuous monitoring and evaluation of preparedness plans and of existing capacities, especially those that are cross-cutting for all-hazards preparedness, was another central topic of the meeting.
Keywords: DISEASE OUTBREAKS - EMERGENCY PREPAREDNESS - INFLUENZA, HUMAN ? PANDEMICS - PUBLIC HEALTH SURVEILLANCE - RISK ASSESSMENT
____
Address requests about publications of the WHO Regional Office for Europe to: Publications, WHO Regional Office for Europe, UN City, Marmorvej 51, DK-2100 Copenhagen ?, Denmark
Alternatively, complete an online request form for documentation, health information, or for permission to quote or translate, on the Regional Office web site (http://www.euro.who.int/pubrequest ).
_____
? World Health Organization 2014
? European Centre for Disease Prevention and Control, Stockholm, 2014, www.ecdc.europa.eu
All rights reserved. The Regional Office for Europe of the World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full.
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers? products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. The views expressed by authors, editors, or expert groups do not necessarily represent the decisions or the stated policy of the World Health Organization.
-
-------
Joint European Centre for Disease Prevention and Control and WHO Regional Office for Europe Consultation on pandemic and all hazard preparedness, 20?21 November 2013 - Bratislava, Slovakia
ABSTRACT
The joint European Centre for Disease Prevention and Control and WHO Regional Office for Europe consultation on pandemic and all-hazard preparedness was held on 20?21 November 2013 in Bratislava, Slovakia. Participants included 80 national focal points for pandemic influenza planning, preparedness and response, and International Health Regulations from the European Union (EU), the European Economic Area, south-eastern Europe, Israel, Switzerland and Turkey. The meeting focussed on cross-cutting issues related to pandemic and all-hazards preparedness in light of the implementation of the IHR and the recently adopted EU Decision 1082/2013/EU on serious cross-border threats to health. Topics including risk mapping, risk assessment and multisectoral coordination were addressed, as was the importance of having compatible preparedness plans both within and between countries. Continuous monitoring and evaluation of preparedness plans and of existing capacities, especially those that are cross-cutting for all-hazards preparedness, was another central topic of the meeting.
Keywords: DISEASE OUTBREAKS - EMERGENCY PREPAREDNESS - INFLUENZA, HUMAN ? PANDEMICS - PUBLIC HEALTH SURVEILLANCE - RISK ASSESSMENT
____
Address requests about publications of the WHO Regional Office for Europe to: Publications, WHO Regional Office for Europe, UN City, Marmorvej 51, DK-2100 Copenhagen ?, Denmark
Alternatively, complete an online request form for documentation, health information, or for permission to quote or translate, on the Regional Office web site (http://www.euro.who.int/pubrequest ).
_____
? World Health Organization 2014
? European Centre for Disease Prevention and Control, Stockholm, 2014, www.ecdc.europa.eu
All rights reserved. The Regional Office for Europe of the World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full.
The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted lines on maps represent approximate border lines for which there may not yet be full agreement.
The mention of specific companies or of certain manufacturers? products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by the World Health Organization to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either express or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall the World Health Organization be liable for damages arising from its use. The views expressed by authors, editors, or expert groups do not necessarily represent the decisions or the stated policy of the World Health Organization.
-
-------